EMLA CREAM AS PAIN RELIEF DURING PNEUMOCOCCAL VACCINATIO
- Conditions
- Pain relief with Emla cream during Pneumococcal vaccination.
- Registration Number
- EUCTR2010-021406-38-SE
- Lead Sponsor
- Mariefreds Vårdcentral
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Healthy children, normal birth or are born with sectio after 37 weeks of gestation and who are not admitted to the neonatal unit. Children should only have been with the PKU testing performed routinely at the hospital.
Are the trial subjects under 18? yes
Number of subjects for this age range: 72
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Baby delivered by vacuum extraction or forceps. Children born before gestational week 37. Children in neonatal care and subjected to other testing than PKU. Shoulder dystocia. Children susceptible to methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia. Children with atopic dermatitis because the application time for Emla-plaster should be shortened to 15-30 minutes
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method